XXII 📈 22nd Century - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90137F1030
XXII: Cigarettes, Tobacco, Plants, Products
22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina. Web URL: https://www.xxiicentury.com
Additional Sources for XXII Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XXII Stock Overview
| Market Cap in USD | 2m |
| Sector | Consumer Defensive |
| Industry | Tobacco |
| GiC Sub-Industry | Tobacco |
| IPO / Inception | 2011-01-26 |
XXII Stock Ratings
| Growth 5y | -78.9% |
| Fundamental | -26.3% |
| Dividend | - |
| Rel. Strength Industry | -648 |
| Analysts | 3/5 |
| Fair Price Momentum | 2.67 USD |
| Fair Price DCF | - |
XXII Dividends
No Dividends PaidXXII Growth Ratios
| Growth Correlation 3m | -94.1% |
| Growth Correlation 12m | -31.4% |
| Growth Correlation 5y | -63.9% |
| CAGR 5y | -69.88% |
| CAGR/Mean DD 5y | -1.10 |
| Sharpe Ratio 12m | 0.79 |
| Alpha | -99.65 |
| Beta | 0.68 |
| Volatility | 263.42% |
| Current Volume | 103.1k |
| Average Volume 20d | 108.9k |
What is the price of XXII stocks?
As of December 22, 2024, the stock is trading at USD 4.95 with a total of 103,080 shares traded.
Over the past week, the price has changed by -46.01%, over one month by -58.72%, over three months by -83.68% and over the past year by -80.00%.
As of December 22, 2024, the stock is trading at USD 4.95 with a total of 103,080 shares traded.
Over the past week, the price has changed by -46.01%, over one month by -58.72%, over three months by -83.68% and over the past year by -80.00%.
Is 22nd Century a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, 22nd Century (NASDAQ:XXII) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.34 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XXII as of December 2024 is 2.67. This means that XXII is currently overvalued and has a potential downside of -46.06%.
Probably not. Based on ValueRay Fundamental Analyses, 22nd Century (NASDAQ:XXII) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.34 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XXII as of December 2024 is 2.67. This means that XXII is currently overvalued and has a potential downside of -46.06%.
Is XXII a buy, sell or hold?
22nd Century has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold XXII.
22nd Century has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold XXII.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for XXII stock price target?
According to ValueRays Forecast Model, XXII 22nd Century will be worth about 2.9 in December 2025. The stock is currently trading at 4.95. This means that the stock has a potential downside of -40.61%.
According to ValueRays Forecast Model, XXII 22nd Century will be worth about 2.9 in December 2025. The stock is currently trading at 4.95. This means that the stock has a potential downside of -40.61%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 720 | 14445.5% |
| Analysts Target Price | 32.4 | 555.4% |
| ValueRay Target Price | 2.9 | -40.6% |